信达证券发布三鑫医疗研报：海外拓展提速，血液净化主业持续高增

Group 1 - The core viewpoint of the report is that Sanxin Medical (300453.SZ) is experiencing accelerated revenue growth, driven by rapid development in overseas markets [2] - The company's main business in blood purification continues to grow significantly, supported by a rich pipeline of products, indicating strong growth momentum [2] Group 2 - The report highlights that the company's income growth is speeding up quarter by quarter, indicating a positive trend in financial performance [2] - The overseas business expansion is a key driver of the company's growth, suggesting a successful strategy in international markets [2]